FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to cardio-oncology and medical genetics, and aims at predicting subacute anthracycline-mediated cardiotoxicity in oncological patients. Method includes genotyping polymorphism rs28714259 on a DNA matrix extracted from blood or buccal epithelium. If genotypes G / A or A / A are present, a high risk of subacute anthracycline-mediated cardiotoxicity is predicted.
EFFECT: invention provides a cheap, easy-to-implement high-information method for predicting the risk of anthracycline-mediated cardiotoxicity in oncological patients before using anthracycline antibiotics.
1 cl, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN WOMEN WITH BREAST CANCER | 2019 |
|
RU2714683C1 |
| METHOD FOR PREDICTING THE PROGRESSION OF CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER AFTER ANTHRACYCLINE CHEMOTHERAPY | 2022 |
|
RU2790788C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER WITHIN 12 MONTHS AFTER CHEMOTHERAPY WITH ANTRACYCLIC DRUGS | 2018 |
|
RU2680139C1 |
| METHOD FOR PERSONALIZED SELECTION OF PATIENTS WITH ANTHRACYCLINE-INDUCED CARDIOMYOPATHY AFTER POLYCHEMOTHERAPY OF BREAST CANCER FOR EFFECTIVE TREATMENT WITH CARVEDILOL | 2021 |
|
RU2778612C1 |
| METHOD FOR PREDICTING PROGRESSION OF ANTHRACYCLINE-INDUCED CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER WITHIN 24 MONTHS | 2022 |
|
RU2793672C1 |
| METHOD FOR PREVENTING ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER | 2014 |
|
RU2546399C1 |
| METHOD FOR PREDICTION OF CUMMULATIVE CARDIAC TOXICITY OF CHEMOTHERAPEUTIC PREPARATIONS | 2012 |
|
RU2510240C2 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF CARDIOTOXICITY IN PATIENTS WITH HER2 POSITIVE BREAST CANCER OF INITIALLY LOW / MODERATE CARDIOVASCULAR RISK RECEIVING A TARGETED THERAPY WITH TRASTUZUMAB AFTER ANTHRACYCLINE-CONTAINING CHEMOTHERAPY | 2020 |
|
RU2741371C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF CHRONIC CARDIAC FAILURE IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2545899C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING SUBCLINICAL LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN THE PATIENTS WITH CHRONIC LYMPHATIC LEUKEMIA IN THE CHEMOTHERAPY IN THE FCR MODE | 2019 |
|
RU2727003C1 |
